Skip to main content
. 2024 Mar 1;42(13):1472–1476. doi: 10.1200/JCO.23.02266

TABLE A2.

Any-Grade TRAEs Leading to Dose Reduction

TRAE Patient (N = 34), No. (%)
Any TRAE leading to dose reduction 13 (38.2)
Pneumonitis 4 (11.8)
Stomatitis 3 (8.8)
Abdominal pain 1 (2.9)
Acute coronary syndrome 1 (2.9)
Dehydration 1 (2.9)
Fatigue 1 (2.9)
Hyperglycemia 1 (2.9)
Increased ALT 1 (2.9)
Increased AST 1 (2.9)
Increased creatinine 1 (2.9)
Thrombocytopenia 1 (2.9)
Weight decreased 1 (2.9)

Abbreviation: TRAE, treatment-related adverse event.